Germany’s Bayer is targeting increased sales and earnings growth over the next few years at its drug and crop-science businesses, just days after announcing a planned $66 billion takeover of U.S. seed supplier Monsanto.
from WSJ.com: US Business http://ift.tt/2czJW37
via IFTTT
No comments:
Post a Comment